Key result
High triglycerides linked to atherosclerosis and a ~48% difference in vascular phenotype versus low levels.
Why the study?
Do circulating triglyceride concentrations correlate with atherosclerotic disease status and vascular phenotype in middle-aged adults?
Observational (n=84)
Do circulating triglyceride concentrations correlate with atherosclerotic disease status and vascular phenotype in middle-aged adults?
Circulating triglyceride levels are significantly associated with vascular phenotype and cardiometabolic risk markers, particularly in healthy controls and sub-clinical groups.
Answers are grounded in this paper and cite their sources.
Does not support practice change; leaves open whether triglycerides causally drive vascular phenotype in atherosclerosis.
A number of food micronutrients are reported to influence markers of cardio-metabolic health. There is an expectation that there may be an optimal endocrine profile, with triglycerides as a key factor, which may help minimise atherosclerotic disease and associated risk factors. This study involved 84 participants aged (mean ± SD) 48.2 ± 8.3 years from both sexes segregated into n = 30 controls, n = 25 at-risk, and n = 29 diagnosed with atherosclerosis, including 20 participants using statins. Atherosclerosis status and risk factors were assessed using a combination of clinical records, C-reactive protein (CRP), blood glucose (FBG), lipids profiles, vascular structural and functional characteristics (including carotid-radial pulse wave velocity (CR-PWV), central systolic blood pressure (C-SBP), peripheral systolic blood pressure (P-SBP), peripheral diastolic blood pressure (P-DBP), carotid intima-media thickness (IMT), and carotid artery inter-adventitial diameter (IAD)). There was a significant difference in triglycerides (TG) levels between the clinical groups (p < 0.05) and between the users and non-users of statin (p < 0.001). Significant associations were distinguished between TG and CRP, FBG, high-density lipoprotein (HDL), C-SBP, P-SBP, P-DBP, CR-PWV, heart rate (HR), and body weight in the pooled sample (p < 0.05). In non-users of statin, TG was associated with C-SBP, P-SBP, P-DBP, and HR. In sub-clinical groups, TG was also associated with most of the blood markers. After controlling for statin use, composite z-score analysis revealed 48%, 2%, and 0% differences in in vivo vascular phenotype between high and low TG subgroups in controls, at-risk, and diagnosed atherosclerosis groups, respectively. Thus, TG levels seem to be good indicators for incidence and risk factors of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Azhar et al. (2018) conducted an observational in Atherosclerosis (n=84). Circulating triglycerides concentration vs. Low triglycerides was evaluated on Difference in in vivo vascular phenotype between high and low TG subgroups in controls (p=<0.05). High circulating triglyceride levels were significantly associated with atherosclerotic disease status and a 48% difference in in vivo vascular phenotype compared to low levels in healthy controls.
Synapse has enriched 10 related papers. Consider them for comparative context: